Mpox cases in US children linked to household contacts or caregivers in descriptive report

A descriptive case series examined exposure sources for mpox cases in children aged ≤12 years in the United States. The report did not specify sample size, study phase, or follow-up duration. No comparator group was included, and primary or secondary clinical outcomes were not reported.

The main finding was that cases were exposed by household contacts or caregivers with mpox. No effect sizes, absolute numbers, p-values, or confidence intervals were provided. The report describes an association, not causation, between household exposure and pediatric mpox cases.

Safety and tolerability data were not reported, including adverse events, serious adverse events, or discontinuations. Key limitations include the descriptive nature without statistical analysis, unknown sample size, and lack of comparison group. The absence of clinical outcome data limits interpretation of disease severity or progression.

As a field report, this provides preliminary descriptive information about potential transmission patterns in households with children. The evidence is insufficient to guide clinical management or quantify transmission risk. Clinicians should recognize this as early descriptive information requiring confirmation through more rigorous study designs.